MVZ Medizinisches Labor Bremen
MVZ Medizinisches Labor Bremen is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
A PHASE I/II STUDY TO EVALUATE THE SAFETY AND EFFICACY OF MEBENDAZOLE IN COMBINATION WITH LOW-DOSE ARA-C IN ELDERLY PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (MAIL)
Sponsor University Medical Center Hamburg-Eppendorf
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Randomized, double-blind, placebo-controlled, multi-centre trial to evaluate the efficacy, safety and tolerability of oral treatment with living bacteria of E. coli DSM 17252 (Symbioflor®2) in patients with diarrhoea-predominant irritable bowel syndrome (IBS-D)
Sponsor SymbioPharm GmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
A phase I/II, single arm, open label study of dasatinib as toxicity prophylaxis in the context of therapy with idecabtagene vicleucel in relapsed/refractory multiple myeloma
Sponsor Universitaetsklinikum Wuerzburg AöR
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for MVZ Medizinisches Labor Bremen?
The 2026-10-09 snapshot links MVZ Medizinisches Labor Bremen to 3 distinct CTIS trials. Recorded services include analysis of pharmacokinetics (PK), Laboratory services, stool analysis. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for MVZ Medizinisches Labor Bremen?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to MVZ Medizinisches Labor Bremen conducted?
The linked trials record locations in 1 country, including Germany. These are trial locations, not confirmed office locations or countries where MVZ Medizinisches Labor Bremen delivered services.
What can this page tell me about MVZ Medizinisches Labor Bremen's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under MVZ Medizinisches Labor Bremen. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- MVZ Medizinisches Labor Bremen GmbH